Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


South Korea’s FTC Looking Into Sanofi Aventis and Novartis For Price Inflation – Industry Insiders

This article was originally published in PharmAsia News

Executive Summary

SEOUL - As South Korea's government agencies move to tighten surveillance on illegal and unfair deals in the pharma industry, the Fair Trade Commission is now looking into several companies including Sanofi-Aventis and Novartis to investigate inflated prices on their products which are considerably more expensive in South Korea than in other countries such as the U.S. and UK, according to industry insiders

You may also be interested in...

South Korea Health Ministry Seeks Legal Grounds Against Doctor Kickbacks

SEOUL - One month after denying it would seek tightened legal restrictions and punishment for doctors who accept kickbacks from pharmaceutical companies, South Korea's Ministry for Health, Welfare and Family Affairs said April 6 it now supports a bill submitted to the National Assembly to suspend licenses of doctors who participate in the practice

Korean Government Fines Five Pharma Multinationals For Unfair Trade

SEOUL - South Korea's trade watchdog, the Fair Trade Commission, has imposed fines collectively totaling KRW 20.48 billion ($14.8 million) on seven pharmaceutical companies - including five multinationals - on charges of unfair provision of rebates and other improper benefits to doctors and hospitals

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts